Schedule 13G ownership disclosure

CONSTELLATION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 210373106

Event date: 2019-10-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,740,945
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-053426
Form type
SC 13G/A
Filer
CONSTELLATION PHARMACEUTICALS INC
CIK
CIK 1434418
Filed
Oct 09, 2019
Reporting period
Oct 03, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub